Georgetown University Hospital — Washington D.C., District of Columbia

Georgetown University Hospital is a clinical research site located in Washington D.C., District of Columbia, United States 20007.

Crixeo Health Trust Score: 90/100 (GOOD). This profile has not yet been claimed by the site owner.

Georgetown University Hospital has participated in 138 clinical trials with 13 currently active.

Therapeutic areas: Solid Tumors, Advanced/Metastatic Clear Cell Renal Cell Carcinoma, Autoimmune Hemolytic Anemia.

Sponsors: Incyte Corporation, Allogene Therapeutics, Clovis Oncology, Inc..

Sponsor Feasibility Report

Trust Score: 90/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Georgetown University Hospital?

Georgetown University Hospital has a Crixeo Trust Score of 90/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Georgetown University Hospital conducted?

Georgetown University Hospital has 138 clinical trials on record, with 13 currently active. Their work covers Solid Tumors, Advanced/Metastatic Clear Cell Renal Cell Carcinoma, Autoimmune Hemolytic Anemia.

Is Georgetown University Hospital accredited by Crixeo Health?

Georgetown University Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Georgetown University Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.